VistaGen Therapeutics (VTGN) Competitor Comparison
We are evaluating the key criteria listed to compare VistaGen Therapeutics (VTGN) against its competitors in the Biotechnology industry.
Market Capitalization
243 / 368Gross Profits
153 / 278Total Revenue
241 / 300EBITDA
123 / 337Free Cashflow
141 / 352Quick Ratio
57 / 357Earnings per Share
128 / 359Dividend yield
0 / 6Total Cash
277 / 358Performance 3 years
335 / 368Performance 5 years
263 / 368Performance 10 years
328 / 368Linearity 3 years
321 / 368Linearity 5 years
114 / 368Linearity 10 years
257 / 367Total Rank
366 / 368Dividend Rank
307 / 368Valuation Rank
252 / 368Piotroski Rank
363 / 368Muliplier Rank
235 / 368Market Capitalization - VTGN ranking 243 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.